or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 196 Cancer Biology PhD Projects, Programmes & Scholarships in the UK
Cancer Biology PhD Projects, Programmes & Scholarships in the UK
We have 196 Cancer Biology PhD Projects, Programmes & Scholarships in the UK
Unlocking the code within the code: Using AI to decipher the role of codon usage in protein synthesis and gene regulation
Research Group:
Hannon Group
Overview. Dr Susanne Bornelöv wishes to recruit a student to work on the project entitled. "Unlocking the code within the code. Using AI to decipher the role of codon usage in protein synthesis and gene regulation". Read more
Multi-modal spatial data integration to predict breast cancer treatment response
Research Group:
Ali Group
Overview. Dr Raza Ali wishes to recruit a student to work on the project entitled. "Multi-modal spatial data integration to predict breast cancer treatment response". Read more
Mapping cellular trajectories in the senescence spectrum
Research Group:
Narita Group
Overview. Professor Masashi Narita wishes to recruit a student to work on the project entitled. "Mapping cellular trajectories in the senescence spectrum". Read more
Immune Hedgehog signalling dynamics in health and disease
Research Group:
De la Roche Group
Overview. Dr Maike de la Roche wishes to recruit a student to work on the project entitled. "Immune Hedgehog signalling dynamics in health and disease". Read more
Delineating piRNA-guided silencing of transposable elements
Research Group:
Hannon Group
Overview. Professor Greg Hannon and Dr Ben Nicholson wish to recruit a student to work on the project entitled. "Delineating piRNA-guided silencing of transposable elements". Read more
Investigate cytoskeletal networks controlling cancer cell migration at the systems level.
Cell migration is fundamental for the existence of multicellular animals, including humans, as certain cells migrate throughout the embryo to form specific tissues. Read more
Investigate the molecular mechanism controlling FEME (Fast Endophilin Mediated Endocytosis) in directed cancer cell migration using CRISPR, biochemistry, and advanced microscopy methods.
Cancer is a devastating disease. more than one in three people in the UK will develop cancer in their lifetime. Metastasis is the primary cause of cancer related deaths. Read more
Molecular Mechanisms of Cancer Progression
The Wells lab has two funded PhD opportunities in the 2024/2025 recruitment round. Opportunity 1 - listed here. MRC-funded DTP programme. Read more
Regulation of mitosis through centrosomal calcium signals and coupled actin dynamics
Background. Cell division and mitosis are at the centre of development and often dysregulated in diseases associated with ageing, like cancer. Read more
Discovery of novel modulators of T cell receptor signalling in cancer
Discovery of novel modulators of T cell receptor signalling in cancer. In cancer and chronic infection, chronically stimulated T cells reduce their function through mechanisms that are not fully understood. Read more
Cancer-associated sensitisation mechanisms to selective RNA methyltransferase inhibition
Project Overview. Epitranscriptomics, the modulation of RNA function via its chemical modification, has emerged as a pervasive new mechanism of gene regulation. Read more
The tipping point: what drives the progression of breast precancer cells
Project Overview. Understanding the molecular and cellular mechanisms of how epithelial tissues maintain a homeostatic state throughout the lifespan of mammals is a major challenge for developmental and stem cell biology. Read more
Rethinking the human proteome: bioactive microproteins in non-Hodgkin lymphoma
Project Overview. The human genome is believed to contain approximately 20,000 protein-coding genes. These were originally annotated based on criteria for predicting synthesis of stable proteins, including an arbitrary size threshold of 100 amino acids. Read more
New therapeutic agents against triple negative breast cancer – targeting an unmet clinical need with the second generation Pol I inhibitor, PMR-116.
This project aims to develop novel therapies for triple-negative breast cancer by combining novel and old drugs to enhance treatment efficacy and reduce side effects. Read more